Publications
- Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)2021 | Third Faculty of Medicine
- Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hodgkin lymphoma - hendless story Hodgkin lymphoma - endless story2019 | Third Faculty of Medicine
- Brentuximab vedotin treatment in clinical practice2018 | Third Faculty of Medicine
- Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials2017 | Third Faculty of Medicine
- Léčba relapsu Hodgkinova lymfomu po autologní transplantaci monoterapií brentuximab vedotinem2017 | Third Faculty of Medicine
- Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group2016 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?2015 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Brentuximab vedotin in the treatment of lymphomas - practical experience2015 | Third Faculty of Medicine
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...